Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo Indication

Anesiva, Inc. today announced that the U.S. FDA has approved Anesiva's supplemental New Drug Application to expand the indication for Zingo to treat the pain associated with blood draws to include adults.

The details can be read here.